Swarnalatha Paka

Title: Swarnalatha Paka: Innovator in Pharmaceutical Chemistry

Introduction

Swarnalatha Paka is a notable inventor based in Elmont, NY (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as inhibitors for Rho-associated coiled-coil kinase (ROCK). Her work is crucial in addressing various medical conditions through innovative therapeutic approaches.

Latest Patents

Swarnalatha holds a patent for "Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors." This invention provides compounds with a specific formula and pharmaceutically acceptable salts. The patent outlines pharmaceutical compositions and methods for treating conditions where inhibiting ROCK1, ROCK2, or both has therapeutic benefits. She has 1 patent to her name, showcasing her innovative contributions to the field.

Career Highlights

Swarnalatha is currently associated with Angion Biomedica Corporation, where she applies her expertise in pharmaceutical development. Her role involves researching and developing new therapeutic agents that can significantly impact patient care and treatment outcomes.

Collaborations

Throughout her career, Swarnalatha has collaborated with esteemed colleagues, including An-Hu Li and Dibyendu Dana. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical sciences.

Conclusion

Swarnalatha Paka is a pioneering inventor whose work in pharmaceutical chemistry is making a difference in the treatment of various diseases. Her innovative spirit and dedication to research continue to inspire advancements in the field.